FI892208A - Foerfarande och mellanprodukt foer framstaellning av aggregationshaemmande peptider. - Google Patents
Foerfarande och mellanprodukt foer framstaellning av aggregationshaemmande peptider. Download PDFInfo
- Publication number
- FI892208A FI892208A FI892208A FI892208A FI892208A FI 892208 A FI892208 A FI 892208A FI 892208 A FI892208 A FI 892208A FI 892208 A FI892208 A FI 892208A FI 892208 A FI892208 A FI 892208A
- Authority
- FI
- Finland
- Prior art keywords
- arg
- alk
- harg
- alpha
- substituted derivative
- Prior art date
Links
- ODKSFYDXXFIFQN-UHFFFAOYSA-N Arginine Chemical compound OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 abstract 6
- 150000001413 amino acids Chemical class 0.000 abstract 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/75—Fibrinogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Hematology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US19151588A | 1988-05-09 | 1988-05-09 | |
US33530689A | 1989-04-10 | 1989-04-10 |
Publications (2)
Publication Number | Publication Date |
---|---|
FI892208A0 FI892208A0 (fi) | 1989-05-08 |
FI892208A true FI892208A (fi) | 1989-11-10 |
Family
ID=26887117
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI892208A FI892208A (fi) | 1988-05-09 | 1989-05-08 | Foerfarande och mellanprodukt foer framstaellning av aggregationshaemmande peptider. |
Country Status (13)
Country | Link |
---|---|
US (1) | US5849690A (fi) |
EP (1) | EP0341915B1 (fi) |
JP (1) | JP2755351B2 (fi) |
KR (1) | KR900018136A (fi) |
AT (1) | ATE158305T1 (fi) |
AU (1) | AU3458889A (fi) |
DE (1) | DE68928321T2 (fi) |
DK (1) | DK222989A (fi) |
FI (1) | FI892208A (fi) |
HU (1) | HU205368B (fi) |
NO (1) | NO891870L (fi) |
PT (1) | PT90512B (fi) |
ZW (1) | ZW6189A1 (fi) |
Families Citing this family (62)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5827821A (en) * | 1987-12-10 | 1998-10-27 | The Burnham Institute | Conformationally stabilized cell adhesion peptides |
WO1989005150A1 (en) * | 1987-12-10 | 1989-06-15 | La Jolla Cancer Research Foundation | Conformationally stabilized cell adhesion peptides |
JPH04503951A (ja) * | 1988-12-20 | 1992-07-16 | ラ ホヤ キャンサー リサーチ ファウンデーション | 創傷治癒に活性のあるポリペプチド―ポリマー複合体 |
US5654267A (en) * | 1988-12-20 | 1997-08-05 | La Jolla Cancer Research Center | Cooperative combinations of ligands contained within a matrix |
US5344783A (en) * | 1989-06-16 | 1994-09-06 | Cor Therapeutics, Inc. | Platelet aggregation inhibitors |
US5795867A (en) * | 1989-06-16 | 1998-08-18 | Cor Therapeutics, Inc. | Platelet aggregation inhibitors |
US5686566A (en) * | 1989-06-16 | 1997-11-11 | Cor Therapeutics, Inc. | Platelet aggregation inhibitors |
US5318899A (en) * | 1989-06-16 | 1994-06-07 | Cor Therapeutics, Inc. | Platelet aggregation inhibitors |
US5384309A (en) * | 1989-07-17 | 1995-01-24 | Genentech, Inc. | Cyclized peptides and their use as platelet aggregation inhibitors |
US5023233A (en) * | 1989-07-28 | 1991-06-11 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
EP0410537A1 (en) * | 1989-07-28 | 1991-01-30 | Merck & Co. Inc. | Fibrinogen receptor antagonists |
US5061693A (en) * | 1989-07-28 | 1991-10-29 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
NZ235564A (en) * | 1989-10-13 | 1993-10-26 | Merck & Co Inc | Fibrinogen receptor antagonist and pharmaceutical compositions |
US5338723A (en) * | 1989-10-13 | 1994-08-16 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
CA2027936C (en) | 1989-10-23 | 2001-07-24 | Smithkline Beecham Corporation | Cyclic anti-aggregatory peptides |
US5643872A (en) * | 1989-10-23 | 1997-07-01 | Smithkline Beecham Corporation | Cyclic anti-aggregatory peptides |
WO1991011458A1 (en) * | 1990-02-02 | 1991-08-08 | Genentech, Inc. | CYCLIC PEPTIDES CONTAINING Arg-Gly-Asp FLANKED BY PROLINE |
DE4009506A1 (de) * | 1990-03-24 | 1991-09-26 | Hoechst Ag | Hydantoinderivate |
US5648330A (en) * | 1990-04-06 | 1997-07-15 | La Jolla Cancer Research Foundation | Method and composition for treating vascular graft occlusion |
US5612311A (en) * | 1990-04-06 | 1997-03-18 | La Jolla Cancer Research Foundation | Method and composition for treating thrombosis |
US5780303A (en) * | 1990-04-06 | 1998-07-14 | La Jolla Cancer Research Foundation | Method and composition for treating thrombosis |
US5672585A (en) * | 1990-04-06 | 1997-09-30 | La Jolla Cancer Research Foundation | Method and composition for treating thrombosis |
US6521594B1 (en) | 1990-04-06 | 2003-02-18 | La Jolla Cancer Research Foundation | Method and composition for treating thrombosis |
AU660926B2 (en) * | 1990-04-06 | 1995-07-13 | La Jolla Cancer Research Foundation | Method and composition for treating thrombosis |
US5192746A (en) * | 1990-07-09 | 1993-03-09 | Tanabe Seiyaku Co., Ltd. | Cyclic cell adhesion modulation compounds |
US5721210A (en) * | 1990-07-09 | 1998-02-24 | Tanabe Seiyaku Co., Ltd. | Cyclic cell adhesion modulation compounds |
CA2092315A1 (en) * | 1990-11-02 | 1992-05-03 | John P. Burnier | Platelet aggregation inhibitors |
EP0570507A4 (en) * | 1991-02-05 | 1994-09-21 | Smithkline Beecham Corp | Anti-aggregatory peptides containing an aromatic ester or amide |
JPH06509551A (ja) * | 1991-04-05 | 1994-10-27 | ジェネンテク,インコーポレイテッド | Gp II↓bIII↓aに対する高い特異性を有する血小板凝集阻害剤 |
WO1993000108A1 (en) * | 1991-06-28 | 1993-01-07 | Corvas International, Inc. | Novel inhibitors of platelet aggregation |
US5939412A (en) * | 1992-06-26 | 1999-08-17 | Smithkline Beecham Corporation | Bicyclic fibrinogen antagonists |
ATE228115T1 (de) * | 1991-06-28 | 2002-12-15 | Smithkline Beecham Corp | Bizyklische fibrinogenantagonisten |
US5635477A (en) * | 1991-09-30 | 1997-06-03 | The Dupont Merck Pharmaceutical Company | Cyclic compounds useful as inhibitors of platelet glycoprotein IIB/IIIA |
IL103252A (en) | 1991-09-30 | 1997-03-18 | Du Pont Merck Pharma | CYCLIC COMPOUNDS USEFUL AS INHIBITORS OF PLATELET GLYCOPROTEIN IIb/IIIa AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
US5250679A (en) * | 1991-10-18 | 1993-10-05 | Genentech, Inc. | Nonpeptidyl platelet aggregation inhibitors having specificity for the GPIIb III.sub. receptor |
US5674865A (en) * | 1991-10-18 | 1997-10-07 | Genentech, Inc. | Nonpeptidyl integrin inhibitors having specificity for the GPIIb IIIa |
US5227490A (en) * | 1992-02-21 | 1993-07-13 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
US5338725A (en) * | 1992-06-30 | 1994-08-16 | The Research Foundation Of The State University Of New York | Anti-aggregatory agents for platelets |
FR2692899B1 (fr) * | 1992-06-30 | 1994-08-19 | Adir | Nouveaux dérivés peptidiques actifs dans les processus d'adhésion cellulaire, leur procédé de préparation et les compositions pharmaceutiques qui les renferment. |
FR2693107B1 (fr) * | 1992-07-01 | 1994-09-23 | Chauvin Laboratoire | Moyens pour la prévention de la cataracte secondaire. |
EP0672059A1 (en) * | 1992-11-18 | 1995-09-20 | The Du Pont Merck Pharmaceutical Company | CYCLIC COMPOUNDS LINKED BY A HETEROCYCLIC RING USEFUL AS INHIBITORS OF PLATELET GLYCOPROTEIN IIb/IIIa |
US5879657A (en) * | 1993-03-30 | 1999-03-09 | The Dupont Merck Pharmaceutical Company | Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders |
EP0705274B1 (en) * | 1993-06-18 | 2000-08-30 | La Jolla Cancer Research Foundation | Method and composition for treating thrombosis |
US5440016A (en) * | 1993-06-18 | 1995-08-08 | Torrey Pines Institute For Molecular Studies | Peptides of the formula (KFmoc) ZZZ and their uses |
MA23420A1 (fr) * | 1994-01-07 | 1995-10-01 | Smithkline Beecham Corp | Antagonistes bicycliques de fibrinogene. |
US6458784B1 (en) | 1994-06-29 | 2002-10-01 | Smithkline Beecham Corporation | Vitronectin receptor antagonists |
AU2958195A (en) * | 1994-06-29 | 1996-01-25 | Texas Biotechnology Corporation | Process to inhibit binding of the integrin alpha 4 beta 1 to vcam-1 or fibronectin |
GB9524630D0 (en) * | 1994-12-24 | 1996-01-31 | Zeneca Ltd | Chemical compounds |
US5977101A (en) * | 1995-06-29 | 1999-11-02 | Smithkline Beecham Corporation | Benzimidazoles/Imidazoles Linked to a Fibrinogen Receptor Antagonist Template Having Vitronectin Receptor Antagonist Activity |
EP0842195A1 (en) * | 1995-07-06 | 1998-05-20 | Zeneca Limited | Peptide inhibitors of fibronectine |
GB9613112D0 (en) | 1996-06-21 | 1996-08-28 | Zeneca Ltd | Chemical compounds |
EA003101B1 (ru) | 1998-03-19 | 2002-12-26 | Бристол-Майерз Сквибб Компани | Двухфазная система доставки с регулируемым высвобождением для фармацевтических средств с высокой растворимостью и способ лечения диабета с помощью этой системы |
CA2328234C (en) | 1998-04-16 | 2009-03-17 | Texas Biotechnology Corporation | Compounds that inhibit the binding of integrins to their receptors |
US6972296B2 (en) | 1999-05-07 | 2005-12-06 | Encysive Pharmaceuticals Inc. | Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
US6723711B2 (en) | 1999-05-07 | 2004-04-20 | Texas Biotechnology Corporation | Propanoic acid derivatives that inhibit the binding of integrins to their receptors |
WO2007082890A1 (en) * | 2006-01-17 | 2007-07-26 | N.V. Organon | SELECTIVE ENZYMATIC HYDROLYSIS OF C-TERMINAL tert-BUTYL ESTERS OF PEPTIDES |
CN107080846A (zh) | 2010-07-09 | 2017-08-22 | 詹姆斯.特林卡.格林 | 用于包括瑞格列净的短半衰期药物的组合立即/延迟释放递送系统 |
US10875875B2 (en) | 2017-04-26 | 2020-12-29 | Aviara Pharmaceuticals, Inc. | Propionic acid derivatives and methods of use thereof |
US20210130393A1 (en) * | 2018-06-15 | 2021-05-06 | Yokogawa Electric Corporation | Method for producing amide |
US20210261610A1 (en) * | 2018-06-15 | 2021-08-26 | Yokogawa Electric Corporation | Method for producing amide |
CN113227019A (zh) * | 2018-12-25 | 2021-08-06 | 国立大学法人东京工业大学 | 酰胺的制备方法 |
EP4000597A1 (en) * | 2020-11-17 | 2022-05-25 | The Boots Company plc | Tetrapeptide and compositions comprising tetrapeptides |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4397842A (en) * | 1980-03-13 | 1983-08-09 | Ortho Pharmaceutical Corporation | Peptides having thymopoietin-like activity |
US4544500A (en) * | 1982-04-14 | 1985-10-01 | Scripps Clinic And Research Foundation | Synthetic foot and mouth disease antigen |
EP0114887B1 (en) * | 1982-08-04 | 1990-11-28 | La Jolla Cancer Research Foundation | Polypeptide |
US4614517A (en) * | 1982-08-04 | 1986-09-30 | La Jolla Cancer Research Foundation | Tetrapeptide |
US4578079A (en) * | 1982-08-04 | 1986-03-25 | La Jolla Cancer Research Foundation | Tetrapeptide |
US4589881A (en) * | 1982-08-04 | 1986-05-20 | La Jolla Cancer Research Foundation | Polypeptide |
US4661111A (en) * | 1982-08-04 | 1987-04-28 | La Jolla Cancer Research Foundation | Polypeptide |
US4517686A (en) * | 1982-08-04 | 1985-05-21 | La Jolla Cancer Research Foundation | Polypeptide |
US4732971A (en) * | 1985-06-03 | 1988-03-22 | Eli Lilly And Company | Synthetic vaccines for foot and mouth disease |
US4683291A (en) * | 1985-10-28 | 1987-07-28 | Scripps Clinic And Research Foundation | Platelet binding inhibitors |
NZ221977A (en) * | 1986-10-09 | 1991-03-26 | Smithkline Beckman Corp | Thrombolytic composition comprising a plasminogen activator (tpa, uk or sk) and a thromboxane synthase inhibitor; kits thereof and process for preparation thereof |
US5352664A (en) * | 1986-10-31 | 1994-10-04 | Board Of Regents, The University Of Texas System | Thrombin derived polypeptides; compositions and methods for use |
CA1311583C (en) * | 1986-12-15 | 1992-12-15 | Gerard Armand Marguerie De Rotrou | Peptide derivatives and their application, in particular in therapy |
US4857508A (en) * | 1987-12-03 | 1989-08-15 | Monsanto Company | Novel platelet-aggregation inhibitor peptide derivatives |
WO1989005150A1 (en) * | 1987-12-10 | 1989-06-15 | La Jolla Cancer Research Foundation | Conformationally stabilized cell adhesion peptides |
AU3040589A (en) * | 1988-02-22 | 1989-09-06 | Upjohn Company, The | Homoarginine-based peptides as platelet aggregation inhibitors |
-
1989
- 1989-05-03 ZW ZW61/89A patent/ZW6189A1/xx unknown
- 1989-05-05 AT AT89304541T patent/ATE158305T1/de not_active IP Right Cessation
- 1989-05-05 DE DE68928321T patent/DE68928321T2/de not_active Expired - Fee Related
- 1989-05-05 DK DK222989A patent/DK222989A/da not_active Application Discontinuation
- 1989-05-05 EP EP89304541A patent/EP0341915B1/en not_active Expired - Lifetime
- 1989-05-08 FI FI892208A patent/FI892208A/fi not_active Application Discontinuation
- 1989-05-08 NO NO89891870A patent/NO891870L/no unknown
- 1989-05-08 HU HU892203A patent/HU205368B/hu not_active IP Right Cessation
- 1989-05-09 JP JP1115915A patent/JP2755351B2/ja not_active Expired - Lifetime
- 1989-05-09 PT PT90512A patent/PT90512B/pt not_active IP Right Cessation
- 1989-05-09 KR KR1019890006198A patent/KR900018136A/ko not_active Application Discontinuation
- 1989-05-09 AU AU34588/89A patent/AU3458889A/en not_active Abandoned
-
1992
- 1992-07-22 US US07/918,487 patent/US5849690A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
NO891870L (no) | 1989-11-10 |
ATE158305T1 (de) | 1997-10-15 |
DK222989A (da) | 1989-11-10 |
EP0341915A2 (en) | 1989-11-15 |
EP0341915B1 (en) | 1997-09-17 |
NO891870D0 (no) | 1989-05-08 |
DE68928321D1 (de) | 1997-10-23 |
FI892208A0 (fi) | 1989-05-08 |
JP2755351B2 (ja) | 1998-05-20 |
PT90512A (pt) | 1989-11-30 |
US5849690A (en) | 1998-12-15 |
DK222989D0 (da) | 1989-05-05 |
KR900018136A (ko) | 1990-12-20 |
JPH0262892A (ja) | 1990-03-02 |
ZW6189A1 (en) | 1990-05-09 |
AU3458889A (en) | 1989-11-09 |
DE68928321T2 (de) | 1998-04-23 |
EP0341915A3 (en) | 1990-12-12 |
PT90512B (pt) | 1994-10-31 |
HUT49891A (en) | 1989-11-28 |
HU205368B (en) | 1992-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI892208A (fi) | Foerfarande och mellanprodukt foer framstaellning av aggregationshaemmande peptider. | |
CA2027936A1 (en) | Cyclic anti-aggregatory peptides | |
KR910006324A (ko) | 펩티다아제 및 아이소머라제 억제제 | |
TW343198B (en) | Cyclopeptides useful as adhesion inhibitors, process for the preparation thereof, and pharmaceutical composition containing them | |
HUP0003592A2 (hu) | LH-RH peptid analógok, alkalmazásuk, és ezeket tartalmazó gyógyászati készítmények | |
EP0162813A3 (en) | Pharmaceutical compositions containing a dipeptide | |
DE69525544D1 (de) | Peptidanaloge des menschlichen, basischen myelinproteins mit substitution an position 91 zur behandlung der multiplen sklerose | |
KR940005669A (ko) | 사이클로펩타이드, 및 점막에 적용시 흡수 촉진제로서의 이의 용도 | |
KR900001719A (ko) | 지질 및 폴리펩티드로 되는 합성 폐 계면활성제의 제조 방법 | |
AU682638B2 (en) | Peptide, bronchodilator and blood flow ameliorant | |
ATE30919T1 (de) | Magensekretion hemmende peptidderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel. | |
ATE84042T1 (de) | Peptide. | |
ATE124955T1 (de) | Substrat-peptide. | |
KR920701242A (ko) | 환원된 비가역성 봄베신 길항제 | |
EP0346068A3 (en) | D-cys6 vasopressin antagonists | |
KR920018074A (ko) | 사이클릭 항-응집성 펩티드 | |
HU910508D0 (en) | Process for producing peptide-analogues and pharmaceutical preparatives containing them | |
TH35998A (th) | Lh-rh เป็ปไทด์ อะนาล็อก ประโยชน์ของสิ่งเหล่านั้นและองค์ประกอบทางเภสัชกรรมซึ่งประกอบด้วยสิ่งเหล่านั้น | |
NZ211403A (en) | Renin-inhibiting peptides and pharmaceutical compositions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Application lapsed | ||
FD | Application lapsed |
Owner name: SMITHKLINE BECKMAN CORPORATION |